ULIHF Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 gruod. 2023 @ 16:39):

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...

Stats
Šios dienos apimtis	100.00
Vidutinė apimtis	0.00
Rinkos kapitalizacija	1.62B
Kita pelno data	( $0 ) 2024-06-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	5.26
ATR14	$0.00400 (0.45%)

Tūris Koreliacija

Ilgas: 0.05 (neutral)

Trumpas: 0.00 (neutral)

Signal:(99.078) Neutral

The United Laboratories Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

The United Laboratories Koreliacija - Valiuta/Žaliavos

-0.81
( strong negative )

-0.36
( neutral )

0.00
( neutral )

-0.27
( neutral )

-0.55
( weak negative )

0.22
( neutral )

The United Laboratories Finansinės ataskaitos

Annual	2023
Pajamos:	$13.74B
Bruto pelnas:	$6.33B (46.11 %)
EPS:	$1.490

FY	2023
Pajamos:	$13.74B
Bruto pelnas:	$6.33B (46.11 %)
EPS:	$1.490

FY	2022
Pajamos:	$11.33B
Bruto pelnas:	$4.97B (43.84 %)
EPS:	$0.870

Financial Reports:

No articles found.

The United Laboratories Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

The United Laboratories

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.